perflutren has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coe, IR; Karshafian, R; Mariglia, J; Momin, S | 1 |
| Hawes, R; Hoffman, B; Romagnuolo, J; Vela, S; Vignesh, S | 1 |
2 other study(ies) available for perflutren and Pancreatic Neoplasms
| Article | Year |
|---|---|
Analysis of the cytotoxic effects of combined ultrasound, microbubble and nucleoside analog combinations on pancreatic cells in vitro.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Deoxycytidine; Flow Cytometry; Fluorocarbons; Gemcitabine; Humans; In Vitro Techniques; Microbubbles; Pancreatic Neoplasms; Ultrasonic Therapy | 2018 |
Accuracy of contrast-enhanced harmonic EUS with a second-generation perflutren lipid microsphere contrast agent (with video).
Topics: Biopsy, Fine-Needle; Contrast Media; Endosonography; Esophageal Neoplasms; Fluorocarbons; Humans; Image Enhancement; Lipids; Liver Neoplasms; Lymphatic Diseases; Microspheres; Pancreatic Neoplasms; Pilot Projects; Prospective Studies; Sensitivity and Specificity | 2011 |